Skip to main content
hpa logo
Topics A-Z:
Search the site:
Home Topics Infectious Diseases Reference Library Acinetobacter species references
Printer friendly page (opens in new window)

Acinetobacter species references

 

HPA CDR-Weekly publications are listed under the Epidemiological data section of the website.

 

2006

Turton JF, et al. Comparison of isolates of Acinetobacter associated with casualties from Iraq in the United Kingdom and United States of America. J Clin Microbiol 2006 [in press].

Turton JF, et al. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006 [in press].

Jones A, et al. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. Lancet Infect Dis 2006 Jun;6:317-318.

Coelho JM, et al. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 2006 Feb;50(2):756-8.

Turton JF, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006 May;258(1):72-7.

Woodford N, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Internat J Antimicrob Agents 2006 Apr;27(4):351-3.

 

 

2005

Huys G, et al. Distribution of tetracycline resistance genes in genotypically related and unrelated multi-resistant Acinetobacter baumannii strains from different European hospitals. Res Microbiol 2005 Apr;156(3):348-55.

Woodford N, et al. Multiplex PCR for Genes Encoding Prevalent OXA Carbapenemases in Acinetobacter spp [poster].   45th ICAAC conference; 2005 Dec; Washington, USA.

 

 

2004

Coelho J, et al. Multiresistant Acinetobacter in the UK: how big a threat? J Hosp Infect 2004 Nov;58(3):167-9

Mushtaq S, et al. Comparative activity of doripenem vs. Enterobacteriaceae and Acinetobacter isolates, mutants and transconjugants with characterized beta-lactamases. Antimicrob Agents Chemother 2004 Apr;48(4):1313-9.

Turton JF, et al. A prevalent, multiresistant, clone of Acinetobacter baumannii in South East England. J Hosp Infect 2004 Nov;58(3):170-9.

Coelho J, et al. Detection of novel OXA-58-like carbapenemase in Acinetobacter spp. from three continents [poster]. Acinetobacter 2004 conference; 2004; Dublin, Eire.

Coelho J, et al. Spread of OXA-23-producing Acinetobacter baumannii clones in England [poster]. 14th ECCMID conference; 2004 May; Prague, Czech Republic.

 

 

2003

Dalla Costa LM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clinical Microbiol 2003 Jul;41(7):3403-6.

Livermore DM. The threat from the pink corner. Ann Med 2003;35(4):226-34.

Coelho J, et al. Epidemiology of Carbapenem-Resistant Acinetobacter spp. in the UK [poster]. 43rd ICAAC conference; 2003 Sep; Chicago, USA.

Mushtaq S, et al. Activity of Doripenem vs. Enterobacteriaceae and Acinetobacter with Characterised Beta-Lactamases [poster]. 43rd ICAAC conference; 2003 Sep; Chicago, USA.

 

 

2002

Henwood CJ, et al. Antibiotic resistance among clinical isolates of Acinetobacter in the United Kingdom and in-vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother 2002 Mar;49(3):479-87.

Lopez-Otsoa F, et al. Endemic carbapenem resistance associated with OXA-40 carbapenemase anong Acinetobacter baumannii isolates from a hospital in northern Spain. J Clin Microbiol 2002 Dec;40(12):4741-3.

Spence RP, et al. Population structure and antibiotic resistance of Acinetobacter DNA groups 2 and 13TU isolates from hospitals in the United Kingdom. J Med Microbiol 2002 Dec;51(12):1107-12.

Tysall L, et al. IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK. J Antimicrob Chemother 2002 Jan;49(1):217-8.

Dalla Costa L, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 enzyme in Brazil [poster]. 42nd ICAAC conference; 2002 Sep; San Diego, USA.

 

 

2001

Afzal-Shah M, et al. Characterization of OXA-25, OXA-26 and OXA-27, molecular class D b-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2001 Feb;45(2):583-8.

Chu Y-W, et al. IMP-4, a novel metallo-b-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 2001 Mar;45(3):710-4.